Detailed Trial Information for Clinical Providers

A Phase I/II Study of Autologous Fat Transfer for Scar Prevention and Remodeling

A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation

Protocol for Composite Facial Allograft

Transplantation

 

A Phase I/II Study of Autologous Fat Transfer for Scar Prevention and Remodeling